Center-Authored Papers

Filters: Author is Husnik, Marla  [Clear All Filters]
2011
McGowan I, Gomez K, Bruder K, Febo I, Chen BA, Richardson BA, Husnik M, Livant E, Price C, Jacobson C.  2011.  Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004).. AIDS (London, England). 25(8):1057-64. Abstract
2014
Guffey BM, Richardson B, Husnik M, Makanani B, Chilongozi D, Yu E, Ramjee G, Mgodi N, Gomez K, Hillier SL et al..  2014.  HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women.. Sexually transmitted infections. Abstract
2016
Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, Mgodi NM, Kiweewa FM, Nair G, Mhlanga F et al..  2016.  Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.. The New England journal of medicine. Abstract
Riddler SA, Husnik M, Gorbach PM, Levy L, Parikh U, Livant E, Pather A, Makanani B, Muhlanga F, Kasaro M et al..  2016.  Long-term follow-up of HIV seroconverters in microbicide trials - rationale, study design, and challenges in MTN-015.. HIV clinical trials. :1-8. Abstract
2017
Riddler SA, Husnik M, Ramjee G, Premrajh A, Tutshana BO, Pather A, Siva S, Jeenarain N, Nair G, Selepe P et al..  2017.  HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial.. PloS one. 12(6):e0178594. Abstract